Calyxt
MENUMENU
  • Discover the Possibilities
  • Work With Us
  • Innovation Pipeline
  • Investors
  • News
  • Careers
Calyxt

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Fact Sheet
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Historical Financial Summary
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Mar 02, 2023 4:01pm EST

Calyxt Reports Fourth Quarter 2022 Financial Results and Provides Corporate Update

Feb 15, 2023 7:30am EST

Calyxt, Inc. Announces its Filing of Registration Statement on Form S-4 in Connection with Merger with Cibus Global LLC

Jan 17, 2023 6:30am EST

Calyxt and Cibus Announce Definitive Merger Agreement to Create Industry-Leading Precision Gene Editing and Trait Licensing Company

Nov 18, 2022 11:00am EST

Calyxt Achieves Phase 1 Milestone in Collaboration Agreement to Develop Alternative to Palm Oil

Nov 17, 2022 4:01pm EST

Calyxt Granted 180-Day Extension by Nasdaq to Regain Compliance with Bid Price Rule

Nov 03, 2022 4:01pm EDT

Calyxt Reports Third Quarter 2022 Financial Results and Provides Corporate Update

Nov 01, 2022 7:00am EDT

Calyxt Joins Bioindustrial Manufacturing and Design Ecosystem (BioMADE), a Department of Defense Initiative, to Advance Sustainable Plant-Based Biomanufacturing

Oct 27, 2022 7:00am EDT

Calyxt to Host Third Quarter 2022 Financial Results Conference Call and Webcast on Thursday, November 3, 2022, at 4:30 p.m. Eastern Time

Oct 25, 2022 7:00am EDT

Calyxt Successfully Produces Plant-Based Squalene, an Important Ingredient in Personal Care Products and Critical Vaccine Adjuvants

Oct 06, 2022 7:00am EDT

Calyxt Announces Agreement with Evologic Technologies to Scale Production of its Plant-based Ingredients

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 16
  • arrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
    • Discover the Possibilities
    • Work With Us
    • Innovation Pipeline
    • Investors
    • News
    • Careers
    • Privacy Policy
    • Terms & Conditions
    • Community Guidelines
    © 2023 Calyxt, Inc. | All Rights Reserved